SMTL ID : 3eta.2 (2 other biounits)

Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x 351: 1-(3-{5-[4-(aminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}phenyl)-3-(2-phenoxyphenyl)urea(Non-covalent)

351.1: 20 residues within 4Å: Chain A: L.24, V.32, A.50, K.52, E.69, V.72, M.73, V.81, V.82, M.98, E.99, L.100, M.101, G.104, F.150, M.161, I.170, G.171, D.172, F.173 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.24, A:L.24, A:V.32, A:A.50, A:K.52, A:V.72, A:V.81, A:F.150 Hydrogen bonds: A:E.69, A:E.69, A:E.99, A:M.101, A:D.172 Water bridges: A:K.52

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Patnaik, S. et al., Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-05-26

Peptides

insulin receptor, kinase domain: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

insulin receptor, kinase domain

Related Entries With Identical Sequence